Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Novo Integrated Sciences Inc
(NQ:
NVOS
)
0.5025
+0.0461 (+10.10%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 24, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Novo Integrated Sciences Inc
< Previous
1
2
3
Next >
Novo Integrated Sciences Signs Agreements for an Unsecured, Non-dilutive Debt Instrument with a Principal Sum of $70,000,000
April 27, 2023
From
Novo Integrated Sciences, Inc.
Via
Business Wire
Novo Integrated Sciences Reports Fiscal Full Year 2022 Financial Results
April 03, 2023
From
Novo Integrated Sciences, Inc.
Via
Business Wire
Novo Integrated Sciences Provides Update on Certain Current Actions and Events
March 24, 2023
From
Novo Integrated Sciences, Inc.
Via
Business Wire
Novo Integrated Sciences Announces Receipt of Notice from Nasdaq
January 30, 2023
From
Novo Integrated Sciences, Inc.
Via
Business Wire
Novo Integrated Sciences Provides Update on Certain Current Actions and Events
January 17, 2023
From
Novo Integrated Sciences, Inc.
Via
Business Wire
Novo Integrated Sciences Announces Receipt of Notice from Nasdaq
December 21, 2022
From
Novo Integrated Sciences, Inc.
Via
Business Wire
Novo Integrated Sciences’ Subsidiary, Clinical Consultants International, Signs Consulting Agreement with Pharmaceutical Research & Development Company, Sarfez Pharmaceuticals, Inc.
November 30, 2022
From
Novo Integrated Sciences, Inc.
Via
Business Wire
Novo Integrated Sciences’ Subsidiary, Clinical Consultants International, Signs Sales & Consulting Agreement with Smart Healthcare Solution Provider, TiaTech USA Inc.
November 08, 2022
From
Novo Integrated Sciences, Inc.
Via
Business Wire
Novo Integrated Sciences’ Subsidiary, Clinical Consultants International, Signs Sales & Consulting Agreement with Tranquility Lifestyle Solutions
October 25, 2022
From
Novo Integrated Sciences, Inc.
Via
Business Wire
Embracing Technology and Innovation “Key” to Easing Healthcare Crisis
August 09, 2022
From
Novo Integrated Sciences, Inc.
Via
Business Wire
Novo Integrated Sciences, Inc. Announces Pricing of $2.0 Million Public Offering
October 13, 2022
From
Novo Integrated Sciences, Inc.
Via
Business Wire
Novo Integrated Sciences Reports Record Revenue of $13.8 million in Fiscal 2022 Third Quarter
July 14, 2022
From
Novo Integrated Sciences, Inc.
Via
Business Wire
Novo Integrated Sciences’ Subsidiary, Clinical Consultants International, Signs Consulting Services Agreement with Information Technology Company, Softhread
October 12, 2022
From
Novo Integrated Sciences, Inc.
Via
Business Wire
Novo Integrated Sciences Announces Preliminary Revenue Range for Fiscal 2022 Third Quarter
July 11, 2022
From
Novo Integrated Sciences, Inc.
Via
Business Wire
Novo Integrated Sciences’ Chairman and CEO to Present at the AAPI CEO Forum on the Future of Healthcare: Technology, Transformation and Beyond
June 23, 2022
From
Novo Integrated Sciences, Inc.
Via
Business Wire
Novo Integrated Sciences’ Chief Medical Officer, Dr. Joseph M. Chalil, Selected as Top Physician of the Year by IAOTP
April 26, 2022
Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the âCompanyâ or âNovoâ), pioneering a holistic approach to patient-first health and wellness through a multidisciplinary healthcare ecosystem of...
Via
PRUnderground
Novo Integrated Sciences’ Chief Medical Officer, Dr. Joseph M. Chalil, Selected as Top Physician of the Year by IAOTP
April 26, 2022
Bellevue, WA, United States - 04-26-2022 -
Via
PR Distribution
Novo Integrated Sciences’ Chief Medical Officer, Dr. Joseph M. Chalil, Selected as Top Physician of the Year by IAOTP
April 26, 2022
From
Novo Integrated Sciences, Inc.
Via
Business Wire
Novo Integrated Sciences Reports Fiscal 2022 Second Quarter Financial Results
April 13, 2022
From
Novo Integrated Sciences, Inc.
Via
Business Wire
Novo Integrated Sciences Completes Acquisition of Clinical Consultants International LLC
April 07, 2022
From
Novo Integrated Sciences, Inc.
Via
Business Wire
Novo Integrated Sciences Signs Memorandum of Understanding with Boditech Med, a Global Point-of-Care Testing Leader, to Market and Distribute in North America
March 29, 2022
From
Novo Integrated Sciences, Inc.
Via
Business Wire
Novo Integrated Sciences’ PRO-DIP® Issued U.S. Patent for Oral Pouch Delivery System Technology
March 24, 2022
From
Novo Integrated Sciences, Inc.
Via
Business Wire
Novo Integrated Sciences Enters into Purchase Agreement to Acquire Clinical Consultants International LLC
March 23, 2022
From
Novo Integrated Sciences, Inc.
Via
Business Wire
Novo Integrated Sciences to Participate in the 2022 Virtual Growth Conference presented by Maxim Group LLC and hosted by M-Vest
March 16, 2022
From
Novo Integrated Sciences, Inc. Novo Integrated Sciences, Inc.
Via
Business Wire
Novo Integrated Sciences’ IoNovo for Kids Pure Iodine Oral Spray Granted Natural Product Number (NPN) by Health Canada
February 18, 2022
From
Novo Integrated Sciences, Inc.
Via
Business Wire
Novo Integrated Sciences Reports First Quarter Financial Results
January 18, 2022
From
Novo Integrated Sciences, Inc.
Via
Business Wire
Novo Integrated Sciences Announces the Signing of a Master Facility License Agreement with LA Fitness in Canada
January 14, 2022
From
Novo Integrated Sciences, Inc.
Via
Business Wire
Novo Integrated Sciences Granted Natural Product Number (NPN) by Health Canada for IoNovo Iodine Branded Product
December 23, 2021
From
Novo Integrated Sciences, Inc.
Via
Business Wire
Novo Integrated Sciences Reports Fiscal Full Year 2021 Financial Results
December 14, 2021
From
Novo Integrated Sciences, Inc.
Via
Business Wire
Novo Integrated Sciences Acquires Majority Stake in Terragenx and Intellectual Property for FDA and Health Canada Approved Water-Soluble Iodine Micro-Nutrient
November 30, 2021
From
Novo Integrated Sciences, Inc.
Via
Business Wire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.